| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |